Literature DB >> 17984932

Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).

Berthold Langguth1, Rainer Wiegand, Alexander Kharraz, Michael Landgrebe, Jorg Marienhagen, Ulrich Frick, Goran Hajak, Peter Eichhammer.   

Abstract

OBJECTIVES: Repetitive transcranial magnetic stimulation (rTMS) is a brain stimulation technique which has received increasing attention as an antidepressant treatment. However available studies are characterized by a substantial variability in response. We hypothesized that individual patients' characteristics might contribute to such heterogeneity. Therefore we investigated whether either alterations of regional cerebral blood flow (rCBF) or clinical characteristics may predict antidepressant response to rTMS.
DESIGN: 24 patients with major depression and stable medication received high frequency (10 Hz) rTMS over the left dorsolateral prefrontal cortex (DLPFC) for two weeks as add-on treatment. ECD-Single photon emission computed tomographay (SPECT) imaging was performed 1 to 2 days before rTMS.
SETTING: Tertial referral center
RESULTS: After two weeks of rTMS a mean reduction of 30% of the initial Hamilton Depression Rating Score (HAMD) was observed. Using a multivariate regression model with simultaneous evaluation of the relative impact of a-priori chosen potential factors influencing treatment outcome, two variables, the pretreatment anterior cingulate rCBF and the former response to antidepressant agents proved significant. High pretreatment anterior cingulate activity and low treatment resistance to pharmacologic therapy were positive predictors for treatment response to rTMS.
CONCLUSIONS: Pretreatment anterior cingulate activity seems to be a useful prognostic marker of rTMS treatment response, which is in line with other treatment strategies, like sleep deprivation, electroconvulsive therapy or antidepressant medication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984932

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  27 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.

Authors:  Marie-Laure Paillère Martinot; Jean-Luc Martinot; Damien Ringuenet; André Galinowski; Thierry Gallarda; Frank Bellivier; Jean-Pascal Lefaucheur; Hervé Lemaitre; Eric Artiges
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

Review 3.  Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

Authors:  B G Bunney; J Z Li; D M Walsh; R Stein; M P Vawter; P Cartagena; J D Barchas; A F Schatzberg; R M Myers; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2014-11-04       Impact factor: 15.992

4.  Accelerated TMS for Depression: A systematic review and meta-analysis.

Authors:  A Irem Sonmez; Deniz Doruk Camsari; Aiswarya L Nandakumar; Jennifer L Vande Voort; Simon Kung; Charles P Lewis; Paul E Croarkin
Journal:  Psychiatry Res       Date:  2018-12-07       Impact factor: 3.222

5.  Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression.

Authors:  Raphaelle Richieri; Laurent Boyer; Jean Farisse; Cecile Colavolpe; Olivier Mundler; Christophe Lancon; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-07       Impact factor: 9.236

6.  Transcranial magnetic stimulation for the treatment of depression: feasibility and results under naturalistic conditions: a retrospective analysis.

Authors:  Elmar Frank; Peter Eichhammer; Julia Burger; Marc Zowe; Michael Landgrebe; Göran Hajak; Berthold Langguth
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08-25       Impact factor: 5.270

7.  Indirect frontocingulate structural connectivity predicts clinical response to accelerated rTMS in major depressive disorder

Authors:  Deborah C.W. Klooster; Iris N. Vos; Karen Caeyenberghs; Alexander Leemans; Szabolcs David; René M.H. Besseling; Albert P. Aldenkamp; Chris Baeken
Journal:  J Psychiatry Neurosci       Date:  2020-07-01       Impact factor: 6.186

8.  Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder.

Authors:  Anne J Blood; Dan V Iosifescu; Nikos Makris; Roy H Perlis; David N Kennedy; Darin D Dougherty; Byoung Woo Kim; Myung Joo Lee; Shirley Wu; Sang Lee; Jesse Calhoun; Steven M Hodge; Maurizio Fava; Bruce R Rosen; Jordan W Smoller; Gregory P Gasic; Hans C Breiter
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

9.  Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression.

Authors:  Shan H Siddiqi; Ravikumar Chockalingam; C Robert Cloninger; Eric J Lenze; Pilar Cristancho
Journal:  J Psychiatr Pract       Date:  2016-05       Impact factor: 1.325

Review 10.  Ketamine and the next generation of antidepressants with a rapid onset of action.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy Diazgranados; Carlos A Zarate
Journal:  Pharmacol Ther       Date:  2009-05-03       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.